Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 52Leukemia, Myeloid, Acute 49Lymphoma, Non-Hodgkin 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Lymphoma 37Leukemia 35Hodgkin Disease 35Myelodysplastic Syndromes 33Lymphoma, Mantle-Cell 20Leukemia, Lymphocytic, Chronic, B-Cell 20Lymphoma, Large B-Cell, Diffuse 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Burkitt Lymphoma 17Lymphoma, Follicular 12Hematologic Neoplasms 12Neoplasms, Plasma Cell 11Congenital Abnormalities 11Lymphoma, B-Cell, Marginal Zone 10Leukemia, Biphenotypic, Acute 9Breast Neoplasms 9Myeloproliferative Disorders 8Lymphoma, Large-Cell, Immunoblastic 8Anemia, Refractory, with Excess of Blasts 8Recurrence 7Leukemia, Myelomonocytic, Juvenile 7Leukemia, Myelomonocytic, Chronic 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Graft vs Host Disease 6Sarcoma 5

Interventions

N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Cryotherapy 2Cholecalciferol 2Cantharidin 22-Propanol 2plerixafor 1methyl 5-aminolevulinate 1green tea extract polyphenone E 1VP-102 1Sugars 1Photochemotherapy 1PRA1 protein, Candida albicans 1Measles-Mumps-Rubella Vaccine 1Maltose 1Interferon-alpha 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Exercise 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Warts × Granulocyte Colony-Stimulating Factor × Clear all
NCT02231879 2023-04-07

Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome

National Institutes of Health Clinical Center (CC)

Phase 2/3 Completed
20 enrolled 10 charts

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Neutropenia, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡